FDA approves first CRISPR therapy-here's how it works against sickle cell

from Ars Technica 10 months ago

"Sickle cell disease is a rare, debilitating and life-threatening blood disorder with significant unmet need, and we are excited to advance the field, especially for individuals whose lives have been severely disrupted by the disease, by approving two cell-based gene therapies today," said Nicole Verdun, director of the Office of Therapeutic Products within the FDA's Center for Biologics Evaluation and Research, said in the FDA's announcement.
Ars Technicahttps://arstechnica.com/science/2023/12/heres-how-the-first-fda-approved-crispr-therapy-works-to-treat-sickle-cell/

Read at Ars Technica

#sickle-cell-disease #gene-therapies #crisprcas9 #fda #healthcare

Collection

[

...

]

FDA approves first CRISPR therapy-here's how it works against sickle cellFDA approves first CRISPR therapy-here's how it works against sickle cell Briefly

FDA approves first CRISPR therapy-here's how it works against sickle cell
FDA approves first CRISPR therapy-here's how it works against sickle cell
Briefly